Edition:
United Kingdom

People: Pfizer Inc (PFE.N)

PFE.N on New York Stock Exchange

36.38USD
18 Sep 2019
Change (% chg)

$-0.12 (-0.33%)
Prev Close
$36.50
Open
$36.58
Day's High
$36.72
Day's Low
$36.26
Volume
6,630,142
Avg. Vol
6,555,970
52-wk High
$46.46
52-wk Low
$33.97

Littman, Dan 

Dr. Dan R. Littman M.D., is the Director of Pfizer Inc.. He is also a member of the National Academy of the Sciences and the Institute of Medicine, and is a Fellow of the American Academy of Arts and Sciences and the American Academy of Microbiology. Dr. Littman received an A.B. in Biochemical Sciences from Princeton University and an M.D. and Ph.D. from Washington University School of Medicine. r. Littman’s background reflects significant achievements in medicine, healthcare and academia. He has served as a faculty member at the NYU Langone Medical Center for more than 20 years and is a renowned immunologist and molecular biologist. Pfizer benefits from his experience, expertise, achievements and recognition in both medicine and science. In addition, his experiences as a member of the National Academy of the Sciences and the Institute of Medicine enables him to bring a broad perspective of the scientific and medical community to the Board.

Basic Compensation

Total Annual Compensation, USD 116,830
Restricted Stock Award, USD 380,000
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 496,830

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Ian Read

19,549,200

Albert Bourla

9,854,560

Frank D'Amelio

7,139,830

Mikael Dolsten

7,070,200

Michael Goettler

--

Angela Hwang

--
As Of  31 Dec 2018